Irritable bowel syndrome: what do the new Rome IV diagnostic guidelines mean for patient management?

, &
The Rome criteria are universally used as inclusion criteria in pharmaceutical clinical trials and have therefore contributed to testing of several irritable bowel syndrome (IBS)-specific drugs. However, clinicians do not routinely use them because they are complex and consequently difficult to remember. Revised Rome diagnostic criteria for IBS and other functional gastrointestinal disorders (FGIDs) were published in May 2016.
This data repository is not currently reporting usage information. For information on how your repository can submit usage information, please see our documentation.